Stay updated with breaking news from Mapi Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Israeli company Mapi could receive milestone payments from Viatris worth tens of millions of dollars, and royalties from sales, if the product ever reaches the market.
Multiple sclerosis and pulmonary arterial hypertension are disease states expected to have new medications in the upcoming year
/PRNewswire/ -- DelveInsight's Spinal Cord Injury Market Insights report includes a comprehensive understanding of current treatment practices, spinal cord...
The products include Indomethacin 50 mg suppositories, Fluocinolone Acetonide Oil 0.01%, GA Depot 40 mg, Saxagliptin Tablets, 2.5 mg and 5 mg
/PRNewswire/ -- The multiple sclerosis market size in US is expected to increase by USD 3.95 billion from 2021 to 2026, with a CAGR of 5.83% according to the...